Article Versions Notes

Beck A, Nowak C, Meshulam D, Reynolds K, Chen D, Pacardo DB, Nicholls SB, Carven GJ, Gu Z, Fang J, et al. Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants. Antibodies. 2022; 11(4):73. https://doi.org/10.3390/antib11040073

Beck, Alain, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, and et al. 2022. "Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants" Antibodies 11, no. 4: 73. https://doi.org/10.3390/antib11040073

Beck, A., Nowak, C., Meshulam, D., Reynolds, K., Chen, D., Pacardo, D. B., Nicholls, S. B., Carven, G. J., Gu, Z., Fang, J., Wang, D., Katiyar, A., Xiang, T., & Liu, H. (2022). Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants. Antibodies, 11(4), 73. https://doi.org/10.3390/antib11040073